Report Library
View More
Wet Age-Related Macular Degeneratio...
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
2025 Biomedtracker Datamonitor Hea...
May 8, 2025
Wet AMD KOL- France
May 8, 2025
Datamonitor Healthcare Oncology: NH...
May 8, 2025
Wet AMD KOL- US, South
May 7, 2025
Datamonitor Healthcare Infectious D...
May 6, 2025
Datamonitor Healthcare CV&Met: Sick...
May 6, 2025
Dealmaking Quarterly Statistics, Q1...
May 5, 2025
Datamonitor Healthcare I&I: Heredit...
May 1, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Datamonitor Healthcare CNS: Insomni...
May 13, 2025
Wet Age-Related Macular Degeneratio...
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
2025 Biomedtracker Datamonitor Hea...
May 8, 2025
Wet AMD KOL- France
May 8, 2025
Datamonitor Healthcare Oncology: NH...
May 8, 2025
Wet AMD KOL- US, South
May 7, 2025
Datamonitor Healthcare Infectious D...
May 6, 2025
Datamonitor Healthcare CV&Met: Sick...
May 6, 2025
Dealmaking Quarterly Statistics, Q1...
May 5, 2025
Datamonitor Healthcare I&I: Heredit...
May 1, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Datamonitor Healthcare CNS: Insomni...
May 13, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/23/25 | AstraZeneca (AZN) | Tagrisso for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/23/25 | Jazz Pharmaceuticals (JAZZ) | Zepzelca for Small Cell Lung Cancer (SCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/23/25 | Obsidian Therapeutics | OBX-115 for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/22/25 | Bicara (BCAX) | BCA101 for Head and Neck Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/22/25 | Kura Oncology (KURA) | Ziftomenib for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
| 04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/03/2025 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 05/13/2025 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 05/13/2025 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |